OTC:OTLC | ROE | Oncotelic Therapeutics, Inc.

Complete source-backed roe history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-3093.55%
2026-03-3193.96%
2025-12-3194.87%
2025-09-30-18.44%
2025-06-30-47.30%
2025-03-31-55.02%
2024-12-31-54.82%
2024-09-30-52.63%
2024-06-30-10.19%
2024-03-31-65.79%
2023-12-31-65.15%
2023-09-30-99.26%
2023-06-30-108.40%
2023-03-3150.25%
2022-12-3126.25%
2022-09-3035.52%
2022-06-3032.04%
2022-03-31-179.83%
2021-12-31-118.04%
2021-09-30-137.79%
2021-06-30-128.59%
2021-03-31-76.85%
2020-12-31-80.72%
2020-09-30-64.12%
2020-06-30-54.11%
2020-03-31-68.29%
2019-12-31-39.27%
2019-09-30-68.97%
2019-06-30-45.11%
2019-03-31-60.01%
2018-12-31-28.92%
2018-09-30796.58%
2018-06-301901.79%
2018-03-313206.87%
2017-12-312856.11%
2017-09-30-840.76%
2017-06-30-284.70%
2017-03-31-162.70%
2016-12-31-109.24%
2016-09-30-89.81%
2016-06-30-77.21%
2016-03-31-63.95%
2015-12-31-53.86%
2015-09-30-42.45%
2015-06-30-37.52%
2015-03-31-36.00%
2014-12-31-43.60%
2014-09-30-38.34%
2014-06-30-32.38%
2014-03-31-37.85%
2013-12-31-136.97%
2013-09-30-101.93%
2013-06-30-100.57%
2013-03-31-185.51%
2012-12-31-177.72%
2012-09-30-155.79%
2012-06-30-163.70%
2012-03-31-142.17%
2011-12-31-109.73%
2011-09-30-87.05%
2011-06-30-264.11%

Annual ROE

DateROE
2025-12-3194.87%
2024-12-31-54.82%
2023-12-31-65.15%
2022-12-3126.25%
2021-12-31-118.04%
2020-12-31-80.72%
2019-12-31-39.27%
2018-12-31-28.92%
2017-12-312856.11%
2016-12-31-109.23%
2015-12-31-53.86%
2014-12-31-43.60%
2013-12-31-136.97%
2012-12-31-177.72%
2011-12-31-109.73%
2010-12-31452.33%
2009-12-31-426.42%